Optimization of composition of ormustine liposomal dosage form

L. L. Nikolaeva; A. V. Lantsova; E. V. Sanarova; A. P. Polozkova; O. L. Orlova; N. A. Oborotova

doi:10.1134/S1995078016030125

Optimization of composition of ormustine liposomal dosage form

Autores: Nikolaeva L.L.¹, Lantsova A.V.¹, Sanarova E.V.¹, Polozkova A.P.¹, Orlova O.L.¹, Oborotova N.A.¹
Afiliações:
1. Blokhin Russian Cancer Research Center
Edição: Volume 11, Nº 5-6 (2016)
Páginas: 371-376
Seção: Article
URL: https://journals.rcsi.science/2635-1676/article/view/219412
DOI: https://doi.org/10.1134/S1995078016030125
ID: 219412

Citar

Texto integral

Acesso aberto
Acesso é fechado

Acesso está concedido
Acesso é fechado

Somente assinantes

Resumo
Sobre autores
Bibliografia
Arquivos suplementares
Estatísticas

Resumo

The improvement of the composition and technology for the preparation of the liposomal dosage form of ormustine is under consideration. Liposomes are prepared from egg lecithin, cholesterol, and PEG-2000-DSPE by the film hydration method, with 0.1% citric acid being added to the composition to stabilize the liposome dispersion. The efficiency of loading with ormustine is (60 ± 5)% and the average vesicle size is (190 ± 20) nm.